%0 Letter
%T Commentary on "Mesothelin CAR-T cells expressing tumor-targeted immunocytokine IL-12 yield durable efficacy and fewer side effects".
%A Wang Y
%A Zhao G
%A Xing S
%A Wang S
%A Li N
%J Pharmacol Res
%V 206
%N 0
%D 2024 Aug 24
%M 38925463
%F 10.334
%R 10.1016/j.phrs.2024.107267